Form 4: Roivant Sciences Director Melissa B. Epperly Reports Share Transactions
SEC Form 4 Filing
Director Melissa B. Epperly of Roivant Sciences Ltd. reports the acquisition of 1,672 common shares and the disposal of 180 common shares to cover tax obligations.
Summary
- Melissa B. Epperly, a director at Roivant Sciences Ltd., reported transactions involving the company's common shares.
- On January 23, 2025, Ms. Epperly acquired 1,672 common shares as part of the company's Non-Employee Director Compensation Plan.
- These shares were fully vested upon grant.
- On the same day, 180 common shares were disposed of at a price of $11.21 per share to cover tax withholding obligations related to the vesting of previously granted shares.
- Following these transactions, Ms. Epperly's direct holdings decreased from 39,709 to 39,529 common shares.
Sentiment
Score: 7
Explanation: The document reflects routine transactions related to director compensation and tax obligations, which are neither particularly positive nor negative. The sentiment is neutral to slightly positive due to the share award.
Positives
- The acquisition of 1,672 shares indicates continued participation in the company's compensation plan.
- The shares were fully vested upon grant, suggesting immediate ownership.
Negatives
- The disposal of 180 shares, while for tax purposes, reduces the director's overall holdings.
Industry Context
This is a routine filing related to director compensation and tax obligations, common in publicly traded companies.
Comparison to Industry Standards
- Director share transactions are a common occurrence in publicly listed companies.
- The use of share awards as part of director compensation is a standard practice.
- The sale of shares to cover tax obligations is also a typical event.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine director compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 01/23/2025 | Date of the share acquisition and disposal transactions. |
| 01/27/2025 | Date the form was signed. |
Keywords
Roivant Sciences, Director, Share Transactions, Common Shares, Non-Employee Director Compensation Plan, Tax Withholding, SEC Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.